EW vs MACIU · P/E 47, rev $1.39B vs $181.0M cap
Edwards Lifesciences Corp (EW) versus Melar Acquisition Corp. I Unit (MACIU) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Melar Acquisition Corp. I Unit (MACIU) is a shell companies company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
MACIU does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MACIU currently screens at market cap $181.0M.
Not investment advice. Open the EW and MACIU stock pages for the full models.
Not investment advice.